Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Zitong Zhao
Affiliation
School of Pharmacy, Wannan Medical College
ORCID
Career Start Year
2012
Papers
81
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36328147
Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
Biochim Biophys Acta Mol Basis Dis
2023
36328147
Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
Biochim Biophys Acta Mol Basis Dis
2023
37765173
Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A.
Pharmaceutics
2023
37752569
Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
J Exp Clin Cancer Res
2023
37623702
Usage of Cell-Free Protein Synthesis in Post-Translational Modification of μ-Conopeptide PIIIA.
Mar Drugs
2023
37416779
Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.
Int J Biol Sci
2023
37464439
MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1.
Chin Med J (Engl)
2023
36807664
Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
Phytother Res
2023
36693832
Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.
Signal Transduct Target Ther
2023
36923525
Erratum: Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.
Theranostics
2023
37489486
Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes.
Cancer Sci
2023
37489486
Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes.
Cancer Sci
2023
37752569
Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
J Exp Clin Cancer Res
2023
37623702
Usage of Cell-Free Protein Synthesis in Post-Translational Modification of μ-Conopeptide PIIIA.
Mar Drugs
2023
37765173
Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A.
Pharmaceutics
2023
37416779
Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.
Int J Biol Sci
2023
37464439
MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1.
Chin Med J (Engl)
2023
36923525
Erratum: Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.
Theranostics
2023
36693832
Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.
Signal Transduct Target Ther
2023
36807664
Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
Phytother Res
2023
35054790
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.
Int J Mol Sci
2022
36246872
Identification of hub genes for early detection of bone metastasis in breast cancer.
Front Endocrinol (Lausanne)
2022
36232768
LACpG10-HL Functions Effectively in Antibiotic-Free and Healthy Husbandry by Improving the Innate Immunity.
Int J Mol Sci
2022
36098222
Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis.
J Pathol
2022
35643957
PTBP1 promotes IRES-mediated translation of cyclin B1 in cancer.
Acta Biochim Biophys Sin (Shanghai)
2022
36207607
A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy.
Br J Cancer
2022
35982901
A Novel ER Stress Mediator TMTC3 Promotes Squamous Cell Carcinoma Progression by Activating GRP78/PERK Signaling Pathway.
Int J Biol Sci
2022
35355934
Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma.
Chin J Cancer Res
2022
36422969
Small Peptides in the Detection of Mycotoxins and Their Potential Applications in Mycotoxin Removal.
Toxins (Basel)
2022
36545680
Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients.
Front Bioeng Biotechnol
2022
35054790
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.
Int J Mol Sci
2022
35643957
PTBP1 promotes IRES-mediated translation of cyclin B1 in cancer.
Acta Biochim Biophys Sin (Shanghai)
2022
35355934
Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma.
Chin J Cancer Res
2022
36545680
Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients.
Front Bioeng Biotechnol
2022
36422969
Small Peptides in the Detection of Mycotoxins and Their Potential Applications in Mycotoxin Removal.
Toxins (Basel)
2022
36246872
Identification of hub genes for early detection of bone metastasis in breast cancer.
Front Endocrinol (Lausanne)
2022
36207607
A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy.
Br J Cancer
2022
36232768
LACpG10-HL Functions Effectively in Antibiotic-Free and Healthy Husbandry by Improving the Innate Immunity.
Int J Mol Sci
2022
36098222
Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis.
J Pathol
2022
35982901
A Novel ER Stress Mediator TMTC3 Promotes Squamous Cell Carcinoma Progression by Activating GRP78/PERK Signaling Pathway.
Int J Biol Sci
2022
34021861
miR-4306 Suppresses Proliferation of Esophageal Squamous Cell Carcinoma Cell by Targeting SIX3.
Cell Biochem Biophys
2021
33953345
Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
Br J Cancer
2021
33771898
Long Noncoding RNA VESTAR Regulates Lymphangiogenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma by Enhancing VEGFC mRNA Stability.
Cancer Res
2021
33766316
Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures.
Anal Chim Acta
2021
34021861
miR-4306 Suppresses Proliferation of Esophageal Squamous Cell Carcinoma Cell by Targeting SIX3.
Cell Biochem Biophys
2021
33495406
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Aging (Albany NY)
2021
34900675
LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex.
Front Oncol
2021
34603487
Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Comput Math Methods Med
2021
33766316
Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures.
Anal Chim Acta
2021
33771898
Long Noncoding RNA VESTAR Regulates Lymphangiogenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma by Enhancing VEGFC mRNA Stability.
Cancer Res
2021
1 - 50 of 162
Column Actions
Search
Recommended Authors
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year
2015
Number of shared co-authors
0
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year
2013
Number of shared co-authors
0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year
2013
Number of shared co-authors
0
Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
Shuhua Li
The First Affiliated Hospital, Sun Yat-sen University
Career Start Year
2012
Number of shared co-authors
0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year
2012
Number of shared co-authors
0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year
2010
Number of shared co-authors
0
Lu Ji
West China Hospital, Sichuan University
Career Start Year
2010
Number of shared co-authors
2
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year
2010
Number of shared co-authors
4
Peiyao Li
Fuzhou University
Career Start Year
2009
Number of shared co-authors
0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year
2008
Number of shared co-authors
2
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year
2006
Number of shared co-authors
0
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year
2006
Number of shared co-authors
4
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year
2004
Number of shared co-authors
1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year
2004
Number of shared co-authors
0
Xiaojie Bian
Fudan University Shanghai Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Haitao Lan
Academy of Medical Sciences, Sichuan Provincial People's Hospital
Career Start Year
2003
Number of shared co-authors
0
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year
2003
Number of shared co-authors
0
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year
2003
Number of shared co-authors
0
Bin Yan
The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
1
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year
2001
Number of shared co-authors
0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year
2001
Number of shared co-authors
1
Fang Zheng
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Career Start Year
2000
Number of shared co-authors
0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year
2000
Number of shared co-authors
1
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
0
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year
1997
Number of shared co-authors
2
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year
1997
Number of shared co-authors
1
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year
1996
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Yongmei Song
Shandong University of Traditional Chinese Medicine
Co-authored papers
42
Qimin Zhan
Peking University Cancer Hospital
Co-authored papers
22
Liyan Xue
Xuzhou Central Hospital
Co-authored papers
12
Leilei Zheng
Co-authored papers
5
Dong Wang
Co-authored papers
2
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Co-authored papers
2
Dakshayani Lomada
Yogi Vemana University
Co-authored papers
1
Li Jin
Fudan University
Co-authored papers
1
Ellen R Richie
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Zhonghe Sun
Jiangsu University
Co-authored papers
1
Jun Wang
Zhongnan Hospital of Wuhan University
Co-authored papers
1
Peilin Zhang
Shandong Management University
Co-authored papers
1
Jami Willette-Brown
Center for Cancer Research, National Cancer Institute
Co-authored papers
1
Huanming Yang
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers
1
Feng Zhu
Basic Medical College, Qingdao University
Co-authored papers
1
Yinling Hu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Susie Su
Zhabei Central Hospital
Co-authored papers
1
Susan R Davis
Co-authored papers
1
Minghui He
The First Affiliated Hospital, Sun Yat-sen University
Co-authored papers
1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
1
Dongxin Lin
Co-authored papers
1
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers
1
Le Kang
Chinese Academy of Sciences
Co-authored papers
1
Zane Gray
Tulane Cancer Center, Tulane School of Medicine
Co-authored papers
1
Young K Song
National Cancer Institute, National Institutes of Health
Co-authored papers
1
1 - 25